Compound ID | 1289
Class: Derivative of 3-bromo-pyruvic acid (3- BPA)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Broad-spectrum antibacterial agent targeting drug-susceptible and -resistant M. tuberculosis and ESKAPE pathogens |
| Institute where first reported: | Department of Biotechnology, National Institute of Pharmaceutical Education and Research; Division of Microbiology, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI); Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH) |
| Year first mentioned: | 2009 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/66144 |
| Guide to Pharmacology: | ethyl bromopyruvate |
| Citation: | https://academic.oup.com/jac/article-abstract/74/4/912/5301660?redirectedFrom=fulltext |